Form 4: SeaStar Medical Director Lobo Acquires Shares in Lieu of Cash Fees

Sentiment:

SEC Form 4


Director Andres Lobo acquired 32,322 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for director services on April 12, 2024.

Summary

  • On April 12, 2024, Andres Lobo, a director of SeaStar Medical Holding Corp, acquired 32,322 shares of common stock.
  • These shares were granted in lieu of a portion of the cash fees due to Lobo for his services as a director.
  • The shares were acquired at a price of $0.
  • Following the transaction, Lobo directly owns 40,300 shares of SeaStar Medical Holding Corp.
  • The shares are fully vested upon issuance.

Sentiment

Score: 6

Explanation: The sentiment is neutral. A director taking shares in lieu of cash can be seen as a positive sign of alignment with shareholders, but it's a fairly routine transaction.

Positives

  • A director taking shares in lieu of cash may signal confidence in the company's future prospects.

Industry Context

Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for smaller companies or those looking to conserve cash. It aligns the director's interests with those of the shareholders.

Stakeholder Impact

  • Shareholders may view the director accepting stock in lieu of cash as a positive sign of commitment to the company's success.

Key Dates

DateDescription
04/12/2024Date of transaction: Andres Lobo acquired shares of common stock in lieu of cash fees.
04/16/2024Date of signature on the Form 4 filing.

Keywords

SeaStar Medical Holding Corp, Director, Andres Lobo, Share Acquisition, Common Stock, Form 4, Director Compensation, Equity, ICU

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.